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Incontinentia pigmenti in a child
with suspected retinoblastoma
Stephanie J. Weiss1,2 , Archana Srinivasan1, Michael A. Klufas3 and Carol L. Shields1*

Abstract
Background: Incontinentia pigmenti is a rare X-linked dominant syndrome caused by mutation in the NEMO/
IKKgamma gene, and characterized by a spectrum of cutaneous, ocular, neurologic and dental abnormalities. In the
eye, findings include retinal vascular non-perfusion, occasionally with traction retinal detachment, retinal fibrosis, and
retinal pigment epithelium defects. These findings can resemble retinoblastoma, especially when vitreoretinal fibrosis
produces leukocoria.
Case report: A 2-month-old girl born full-term presented with leukocoria, suspicious for retinoblastoma. She was
found to have an ischemic retrolental fibrovascular retinal detachment. In addition, there was linear cutaneous hyperpigmentation, diagnostic of incontinentia pigmenti.
Conclusions: Retinoblastoma can be a challenge to diagnose. There are numerous simulating lesions that can
present with leukocoria and retinal detachment, including incontinentia pigmenti. Recognition of the cutaneous
features of incontinentia pigmenti contributes to early detection of related ophthalmologic, neurologic and dental
abnormalities.
Keywords: Eye, Incontinentia pigmenti, Bloch–Sulzberger syndrome, Retinoblastoma, Pseudoretinoblastoma, Retinal
detachment
Background
Incontinentia pigmenti (IP), also known as Bloch–Sulzberger syndrome, is a rare X-linked dominant syndrome
typically lethal in males, defined by characteristic skin
findings along with ocular, neurologic and dental abnormalities [1–6]. The pathogenesis of IP is attributed to a
mutation in the NEMO/IKKgamma gene located at the
Xq28 loci, which leads to the activation of eotaxin which
stimulates accumulation of eosinophils in tissue [1–5].
In the skin, IP manifests with a staged rash consisting of
erythema, vesicles and pustules at birth, followed by verrucous lesions that evolve into swirled flat hyperpigmentation along the lines of Blaschko, ultimately resulting in
linear, atrophic, hypo- and hyper-pigmented streaks [2–
4]. Dental abnormalities include adontia and/or pegged
and widely spaced teeth [2–5]. Neurologic manifestations
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are varied and include seizures, mental retardation, cerebral atrophy, corpus callosum hypoplasia and hemorrhagic necrosis [1–6]. These neurologic findings are
closely related to the ophthalmologic manifestations,
thought to be caused by similar eosinophilic vasoocclusive phenomena [2, 4, 5].
Incontinentia pigmenti-related ocular abnormalities
have been reported in 50–77% of patients, with retinal
features being the most striking [1, 2, 4, 5, 7]. These findings include retinal vascular non-perfusion with pathologic neovascularization that may progress to tractional
retinal detachment with retrolental fibrous tissue [1,
3–6]. Other retinal findings include foveal hypoplasia,
hyperpigmentated/hypopigmentated retinal pigment
epithelial (RPE) defects, and nodular RPE proliferation
[1–6]. Recently, optical coherence tomography (OCT)
imaging in patients with incontinentia pigmenti has
shown inner and outer retinal layer thinning associated
with incontinentia pigmenti [8]. Rarely, ocular abnormalities associated with IP have been reported to simulate
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retinoblastoma in that both can manifest leukocoria,
strabismus, retinal detachment and intraocular calcification [3]. We present a 2-month-old female who presented
with leukocoria, suspicious for retinoblastoma, but found
to have classic cutaneous and ocular manifestations of IP.

Case presentation
A 2-month-old Asian-Indian female born full-term at
39 weeks gestation and weighing 2.92 kg at birth was
found at 6 weeks of age to have leukocoria of the right
eye, suspicious for retinoblastoma. She was referred to
the Ocular Oncology Service at Wills Eye Hospital for
further evaluation.
On examination, visual acuity was no fix or follow in
the right eye (OD) and fix and follow in the left eye (OS).
Intraocular pressures were 13 mm Hg OD and 16 mm
Hg OS. The anterior segment examination revealed
microcornea with horizontal diameter of 10 mm OD,
scattered posterior synechiae of the iris, and dense retrolental fibrovascular membrane with anterior and centripetal displacement of the ciliary processes (Fig. 1a, b). On
anterior examination, OS appeared normal with horizontal corneal diameter of 11 mm.
Fundus examination OD revealed a total closed-open
funnel tractional retinal detachment with contraction posterior to the lens and anterior loop fibrovascular contraction. There was mild hemorrhage inferiorly
within the vitreous cavity (Fig. 1c). Fundus examination
OS was normal without evidence of peripheral traction or retinal detachment (Fig. 1d). Fluorescein angiography (FA) revealed diffuse late hyperfluorescence
and leakage consistent with retinal neovascularization
OD. FA OS exhibited normal arterial and venous filling with no evidence of peripheral hypofluoresence
consistent with nonperfusion in late frames. There was
no evidence of leakage OS (Fig. 1e, f ). Magnetic resonance imaging (MRI) of the brain and orbits disclosed
total retinal detachment with a decreased axial length of
17.1 mm OD compared to 18.0 mm OS. These features
were suggestive of tractional retinal detachment with
microphthalmia OD.
The parents denied other family members with similar
findings. They indicated that the infant was found at birth
to have a vesicular cutaneous rash over the entire body
that spontaneously resolved. Cutaneous examination disclosed extensive linear hyperpigmented streaks along the
lines of Blashko (Fig. 1g, h). Given the ocular and cutaneous features, the diagnosis of incontinentia pigmenti was
suspected and confirmed on skin biopsy. The pain-free
OD was managed conservatively with observation. Given
the risk for future ischemia OS, close serial examination
with FA was advised.
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Discussion and conclusions
Retinoblastoma typically appears as a yellow-white retinal
mass, often with surrounding subretinal fluid, subretinal
seeds and vitreous seeds [9]. The presenting symptoms for
retinoblastoma most often include leukocoria and strabismus [9]. However, similar findings can be associated with
a broad spectrum of other pediatric fundus abnormalities, leading to diagnostic uncertainty [9]. In a large study
of 604 cases of pseudoretinoblastoma published by Shields
et al. in 2012, the most common conditions simulating retinoblastoma and leading to incorrect diagnosis included
Coats disease (40%), persistent fetal vasculature (28%),
vitreous hemorrhage (5%), toxocariasis (4%), familial exudative vitreoretinopathy (3%), rhegmatogenous retinal
detachment (3%), coloboma (3%), astrocytic hamartoma
(2%), combined hamartoma of retina and RPE (2%), and
endogenous endophthalmitis (2%) [9]. In that study, incontinentia pigmenti was reported in only 2 cases, accounting
for <1% of pseudoretinoblastoma cases [9].
Due to its rarity, a high index of suspicion is often
required to make an accurate diagnosis of incontinentia
pigmenti. Early detection is critical to maximize visual
potential and prevent retinal detachment, as well as avoid
other systemic comorbidities including potentially lifethreatening neurologic manifestations, such as stroke,
coma, and death from brain ischemia [1–6]. Ocular
abnormalities are recorded in approximately 50–77% of
patients with incontinentia pigmenti, and include microphthalmia, corneal opacities, iris hypoplasia, cataract
formation, optic nerve atrophy, macular hypoplasia and
RPE abnormalities as well as retinal and choroidal vascular ischemia that leads to neovascularization with traction retinal detachment and vitreous hemorrhage [5, 7].
OCT in areas of non-perfusion in patients with IP has
been shown to have thinning involving inner retinal layers as well as the outer plexiform layer which is present
prior to laser treatment and remains stable over time
indicating vascular abnormalities during the developmental process [8]. Neurologic findings are detected in
approximately 30% of patients and include corpus callosum hypoplasia, seizures, mental retardation, cerebral
atrophy, and hemorrhagic necrosis [4]. The ocular and
neurologic findings are thought to be caused by similar
vasoocclusive events, secondary to eosinophil accumulation within and around vessels [1–5]. These abnormalities are a result of a mutation in the NEMO/IKK gamma
gene, found on the X chromosome, that functions as a
part of the nuclear factor kappa B (NFkB) signaling pathway that controls several chemokines including eotaxin
(an eosinophil chemokine) [1, 3, 5]. Mutation of this gene
leads to an increase in eosinophil activation through the
NFkB pathway via eotaxin as well as several cytokines
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Fig. 1 Clinical features of incontinentia pigmenti. A 2-month-old Asian Indian female was found at 6 weeks of age to have leukocoria of the right
eye (a) with a normal appearing left eye (b). Fundus examination of the right eye revealed a tractional retinal detachment (c) behind the lens, dragging the pars plicata inward and producing vitreous hemorrhage inferiorly. The left fundus (d) was normal. Fluorescein angiography of the right eye
(e) revealed marked hyperfluorescence with diffuse leakage suggestive of neovascularization and the left eye (f) was healthy with normal perfusion.
(g) Involuting cutaneous vesicular lesions and (h) linear hyperpigmentation (lines of Blaschko) were consistent with incontinentia pigmenti
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including granulocyte-monocyte colony-stimulating factor and interleukin 5 [4].
In addition to the ocular and neurologic vasoocclusive
phenomena, this mutation is also responsible for cutaneous and dental abnormalities associated with incontinentia pigmenti [1, 3, 5]. Reported to be found in 90–100%
of patients, the staged cutaneous rash is pathognomonic
for IP and progresses from a vesicular rash with pustules
and erythema from birth to 2 weeks of age, followed
by verrucous lesions by 2–6 weeks of age, then swirled
flat hyperpigmentation along the lines of Blaschko by
12–26 weeks of age, finally leading to linear, atrophic,
hypo- and hyper-pigmented streaks in adulthood [4, 9].
The rash is caused by eosinophil accumulation in intraepidermal vesicles with significant inflammation (stage
1) which later transforms into epidermal hyperkeratosis
with persistent eosinophilia (stage 2) followed by postinflammatory melanin deposition (stage 3) and epidermal atrophy (stage 4) [4]. Despite the serious nature of
the ocular and neurologic manifestations, the cutaneous
findings are often first noted and strongly suggestive of
the underlying diagnosis [4, 6]. Dental abnormalities,
found in 80% of cases, include pegged and widely spaced
teeth and adontia [4]. These typically are noted at the
time of tooth eruption, and dental evaluation is recommended by age 2 years [4]. Evaluation of mother and
other female siblings could reveal similar dental problems [4].
Several reports have been published describing the
wide array of initial ophthalmologic findings associated
with incontinentia pigmenti, but given its rarity, long
term follow up of the natural progression and treatment
outcomes is limited. Chen et al. published on the retinal
findings in 25 patients with incontinentia pigmenti, with
mean follow up of 9.3 years, and noted high risk for tractional (28%) or rhegmatogenous (16%) retinal detachment in the presence of neovascularization [1]. However,
despite prophylactic laser ablation to areas of retinal
vascular non-perfusion, 3 of 4 eyes went on to develop
tractional retinal detachment [1]. In addition, neovascularization has been shown to remain stable or regress
spontaneously in some cases, making laser photocoagulation controversial [1].
Retinoblastoma is a serious ocular malignancy in children and can be a challenge to diagnose [3, 9, 10]. There
are numerous simulating lesions that can present with
leukocoria and retinal detachment, particularly in a
young child, including incontinentia pigmenti [3, 9, 10]
The defining features of incontinentia pigmenti, the cutaneous blisters and pigmentation, contribute to early recognition and anticipation of related neurologic, dental,
and ophthalmologic abnormalities.
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